Document is current
Any future updates will be listed below
-
Authors
Turan, Raife Dilek
Tastan, Cihan
Dilek Kancagi, Derya
Yurtsever, Bulut
Sir Karakus, Gozde
Ozer, Samed
Abanuz, Selen
Cakirsoy, Didem
Tumentemur, Gamze
Demir, Sevda
Seyis, Utku
Kuzay, Recai
Elek, Muhammer
Kocaoglu, Miyase Ezgi
Ertop, Gurcan
Arbak, Serap
Acikel Elmas, Merve
Hemsinlioglu, Cansu
Hatirnaz Ng, Ozden
Akyoney, Sezer
Sahin, Ilayda
Kayhan, Cavit Kerem
Tokat, Fatma
Akpinar, Gurler
Kasap, Murat
Kocagoz, Ayse Sesin
Ozbek, Ugur
Telci, Dilek
Sahin, Fikrettin
Yalcin, Koray
Ratip, Siret
Ince, Umit
Ovali, Ercument
-
Funding
Funding for this research was provided by:
Acibadem Healthcare Group
TUBITAK-BIDEB 2244-University-Industry PhD program (118C082, 118C082)
TUBITAK 2247-C Trainee Researcher Scholarship Program
- License Information
-
More Information
Article History
Received: 21 March 2021
Accepted: 21 July 2021
First Online: 4 August 2021
Competing interests
: C.T., D.D.K., B.Y., G.S.K., S.D., G.T., Dilek Telci, F.S., and E.O. are inventors of patent applications (pending) including “A Method For The Production Of Fast, Inclusive And High-Dose Inactive Vaccine For Use Against SARS-CoV-2 Virus” (2020/13279) and “A Fast, Inclusive And High-Dose Inactive Method For Adjuvant Positive Vaccination To Be Used Against SARS-CoV-2 Virus” (2020/14033) at Turkish Patent and Trademark Office. No other author has a competing interest except for these authors.
